0 Items
Select Page

Our Coronavirus Pipeline

The Native Antigen Company is developing an extensive range of antigens and antibodies for the human coronaviruses, including SARS-CoV-2 (disease, COVID-19). Please click on the available products below to see what we have available. If we are not currently developing something that you’re interested in, please get in touch through the form below, as we may be able to develop it for you.

Antigens

 

Left: Spike RBD tested as solid-phase bound capture antigen at 2μg/ml with a SARS-CoV-2 IgG ELISA. 5 SARS-CoV-2 PCR-positive patient samples vs. 11 negative controls at 1:400 sample dilution. Right: Spike RBD tested as solid-phase bound capture antigen at 2μg/ml in combination with an RBD-biotin conjugate as soluble detector/tracer at 1μg/ml with a SARS-CoV-2 IgG ELISA. 5 SARS-CoV-2 PCR-positive patient samples vs. 11 negative controls at 1:160 sample dilution.

Virus
S1
S2
Whole Spike
Nucleoprotein
S1 NTD
S1 RBD
 
SARS-CoV
 
Antigens available
Antigens in early development
Antigens in early development
Antigens available
Antigens in early development
Nothing yet scheduled
 
SARS-CoV-2
 
Antigens available
Antigens available
Antigens available
Antigens available
Antigens available
Antigens available
 
MERS-CoV
 
Antigens available
Nothing yet scheduled
Nothing yet scheduled
Antigens in late development
Nothing yet scheduled
Nothing yet scheduled
 
OC43-CoV
 
Antigens in early development
Nothing yet scheduled
Antigens in early development
Antigens in late development
Nothing yet scheduled
Nothing yet scheduled
 
HKU1-CoV
 
Antigens in early development
Nothing yet scheduled
Antigens in early development
Antigens in late development
Nothing yet scheduled
Nothing yet scheduled
 
229E-CoV
 
Antigens in early development
Nothing yet scheduled
Antigens in early development
Antigens available
Nothing yet scheduled
Nothing yet scheduled
 
NL63-CoV
 
Antigens in early development
Nothing yet scheduled
Antigens in early development
Antigens available
Nothing yet scheduled
Nothing yet scheduled

Antibodies

Virus
S1
S2
Whole Spike
Nucleoprotein
S1 NTD
 
SARS-CoV
 
Antibodies in early development
Antibodies available
Nothing yet scheduled
Antibodies available
Nothing yet scheduled
 
SARS-CoV-2
 
Antibodies available
Antibodies available
Nothing yet scheduled
Antibodies available
Nothing yet scheduled
 
MERS-CoV
 
Antibodies available
Nothing yet scheduled
Nothing yet scheduled
Nothing yet scheduled
Nothing yet scheduled

Would you like to be kept informed of the latest news and innovations from the infectious disease community? Please let us know if you would like us to contact you or not by selecting one of the options below.

2 + 14 =

Join our mailing list

* indicates required